Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sandro Spiller"'
Publikováno v:
Clinical Proteomics, Vol 14, Iss 1, Pp 1-9 (2017)
Abstract Background Recent epidemiological studies indicate that only 30–50% of undiagnosed type 2 diabetes mellitus (T2DM) patients are identified using glycated hemoglobin (HbA1c) and elevated fasting plasma glucose (FPG) levels. Thus, novel biom
Externí odkaz:
https://doaj.org/article/a1a6739ebc914c44b7e02430da7850f2
Autor:
Ellen C. Gleeson, Janease E. Graham, Sandro Spiller, Irina Vetter, Richard J. Lewis, Peter J. Duggan, Kellie L. Tuck
Publikováno v:
Marine Drugs, Vol 13, Iss 4, Pp 2030-2045 (2015)
A set of fluorophenoxyanilides, designed to be simplified analogues of previously reported ω-conotoxin GVIA mimetics, were prepared and tested for N-type calcium channel inhibition in a SH-SY5Y neuroblastoma FLIPR assay. N-type or Cav2.2 channel is
Externí odkaz:
https://doaj.org/article/2cdb44de3de74a758f7860ce4082332a
Publikováno v:
Pharmaceuticals, Vol 11, Iss 2, p 38 (2018)
Current screening tests for type 2 diabetes mellitus (T2DM) identify less than 50% of undiagnosed T2DM patients and provide no information about how the disease will develop in prediabetic patients. Here, twenty-nine protein glycation sites were quan
Externí odkaz:
https://doaj.org/article/5b8a4bc682d54e50b34e166373da2327
Autor:
Sandro Spiller
Publikováno v:
Goldschmidt2022 abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8682d4af0bfaa8435fb447fef1de308f
https://doi.org/10.46427/gold2022.12778
https://doi.org/10.46427/gold2022.12778
Autor:
Jeffrey R. McArthur, Sandro Spiller, Peter J. Duggan, Ellen C Gleeson, Kellie L. Tuck, Richard J. Lewis, Leonid Motin, David J. Adams
Publikováno v:
British Journal of Pharmacology. 175:2284-2295
Background and purpose Voltage-gated calcium channels are involved in nociception in the CNS and in the periphery. N-type (Cav 2.2) and T-type (Cav 3.1, Cav 3.2 and Cav 3.3) voltage-gated calcium channels are particularly important in studying and tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79ac989dbc52554501fb8cbb89d78355
https://doi.org/10.1111/bph.13910
https://doi.org/10.1111/bph.13910
Publikováno v:
Pharmaceuticals; Volume 11; Issue 2; Pages: 38
Current screening tests for type 2 diabetes mellitus (T2DM) identify less than 50% of undiagnosed T2DM patients and provide no information about how the disease will develop in prediabetic patients. Here, twenty-nine protein glycation sites were quan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::4d9474f7d9ea0c2b5b128c909300896b
Publikováno v:
Diabetes, obesitymetabolism. 20(11)
Aims Free fatty acids (FFA) mediate adverse metabolic effects such as downregulated carbohydrate metabolisms, providing causal links between obesity and the development of type 2 diabetes mellitus (T2DM). Here, we investigated the plasma concentratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eec3c3aaee6bffbe5ced2aad3251922
https://pubmed.ncbi.nlm.nih.gov/29943387
https://pubmed.ncbi.nlm.nih.gov/29943387
Publikováno v:
Protein & Peptide Letters. 24
Background Type 2 diabetes mellitus (T2DM) is the most common lifestyle disease affecting all countries. Due to its asymptomatic onset, it is often diagnosed after irreversible vascular complications have been initiated. Therefore, specific markers c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b351c21655bf291b62d82b0427869e9
https://doi.org/10.2174/0929866524666170202124120
https://doi.org/10.2174/0929866524666170202124120
Publikováno v:
Pharmaceuticals, Vol 11, Iss 2, p 38 (2018)
Pharmaceuticals
Pharmaceuticals
Current screening tests for type 2 diabetes mellitus (T2DM) identify less than 50% of undiagnosed T2DM patients and provide no information about how the disease will develop in prediabetic patients. Here, twenty-nine protein glycation sites were quan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a2072e6e898ec4214a8f5e5d73d541c6
https://ul.qucosa.de/id/qucosa:84602
https://ul.qucosa.de/id/qucosa:84602
Autor:
Peter J. Duggan, Sandro Spiller, Richard J. Lewis, Ellen C Gleeson, Kellie L. Tuck, Janease Erin Graham, Irina Vetter
Publikováno v:
Marine Drugs
Marine Drugs, Vol 13, Iss 4, Pp 2030-2045 (2015)
Volume 13
Issue 4
Pages 2030-2045
Marine Drugs, Vol 13, Iss 4, Pp 2030-2045 (2015)
Volume 13
Issue 4
Pages 2030-2045
A set of fluorophenoxyanilides, designed to be simplified analogues of previously reported ω-conotoxin GVIA mimetics, were prepared and tested for N-type calcium channel inhibition in a SH-SY5Y neuroblastoma FLIPR assay. N-type or Cav2.2 channel is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43789c2e06af8663af1577dbb910d70d
http://europepmc.org/articles/PMC4413198
http://europepmc.org/articles/PMC4413198